Skip to Main Content

Yesterday, I lauded the best biopharma CEOs of 2018. Today, I give a side-eye glance to the worst.

To land on this ignominious list, biopharma CEOs had to screw up so badly over the past 12 months to set off my outrage alarm. Serial incompetence is also a qualifier. You’d think I would have trouble finding four nominees. You’d be wrong. The hard part for me is narrowing down the list to just four finalists. Enjoy your reading. You’ll get a chance to vote at the bottom of this post.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.